Skin-cancer drug

摘要

An eagerly awaited treatment for late-stage melanoma - the deadliest form of skin cancer - was approved by the US Food and Drug Administration on 25 March. Sales of ipilimumab (Yervoy), made by Bristol-Myers Squibb of New York, could reach more than US$1 billion a year, analysts predict. See page 561 for more.